FDA clears test to detect genetic markers for certain antibiotic-resistant bacteria
The FDA cleared for marketing the Xpert Carba-R Assay, an infection control aid that tests patient specimens to detect specific genetic markers associated with bacteria that are resistant to Carbapenem antibiotics. The Xpert Carba-R Assay is manufactured by Cepheid, located in Sunnyvale, Calif. June 29, 2016